Author:
Shin Su Rin,Yoo Byung Chul,Choi Moon Seok,Lee Dong Ho,Song Soon Mi,Lee Joon Hyoek,Koh Kwang Cheol,Paik Seung Woon
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107
2. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009;50:227–242
3. Niu C, Murakami E, Furman PA. Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytes. Antivir Ther 2008;13:263–269
4. Asselah T, Lada O, Moucari R, Marcellin P. Clevudine: a promising therapy for the treatment of chronic hepatitis B. Expert Opin Investig Drugs 2008;17:1963–1974
5. Balakrishna Pai S, Liu SH, Zhu YL, Chu CK, Cheng YC. Inhibition of hepatitis B virus by a novel l-nucleoside, 2′-fluoro-5-methyl-beta-l-arabinofuranosyl uracil. Antimicrob Agents Chemother 1996;40:380–386
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献